Thus, in direct comparison to the GHS-R1α-binding AG, it is tempting to speculate that GHS-R1α/CD36 co-binding ghrelin analogs may be a superior choice for the amelioration of Aβ-driven microglial inflammation and ROS-production in AD. This evidence concerns the gene GHRL and Alzheimer disease.